Who can relate? 😂 x.com/buitengebieden…

A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer : A Report from #APCCC24 LINK TO ARTICLE👇👇👇👇👇👇👇👇 sciencedirect.com/science/articl… The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in

gorgeous

Local Treatment (1ry Tumor and Metastases) in Metastatic Prostate Cancer out on European Urology Focus by Paul Sargos and team sciencedirect.com/science/articl… Over the past decade, advancements in treating mHR #ProstateCancer have improved OS Nicolas Benziane-Ouaritini Alberto Bossi

Extended lymphadenectomy reduces metastasis in prostate cancer. Results of a large RCT are here! sciencedirect.com/science/articl… UrologyMSK European Urology European Association of Urology (EAU) Confederación Americana de Urología (CAU) #AUAMembers #aua #urology #ProstateCancer Andrew Vickers

During #APCCC24 ,treatment preferences for patients with high-risk localized or locally advanced #ProstateCancer (STAMPEDE definition) and negative nodal and metastatic status (N0 M0) on next-generation imaging Link:sciencedirect.com/science/articl… ✅68% of respondents favored

New Video! Cardiovascular risks of ARSIs in #ProstateCancer: Meta-analysis findings. Rashid K. Sayyid USC & Zach Klaassen Georgia Cancer Center emphasize the importance of comprehensive cardiovascular assessment before initiating ARSI treatment > bit.ly/3TJ1lNy JAMA Oncology

Advances in cancer immunotherapies Cell

Results after Four Years of Screening for Prostate Cancer with PSA and MRI Out on the New England This population-based trial investigated the efficacy and safety of using MRI in #ProstateCancer screening among men aged 50 to 60 with elevated PSA levels. Participants were

A great Pleasure to Present the first Advanced Prostate Cancer Consensus Conference #APCCC24 Webinar on Management of patients with Advanced #ProstateCancer : Cases from #APCCC24 LINK TO ARTICLE👇👇👇👇👇👇👇👇 sciencedirect.com/science/articl… ENTIRE WEBINAR HERE in this post The 2024 Advanced Prostate Cancer

How polar bears move to cross thin ice

Loving dad

No Better way to start 2025 A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer A Report from #APCCC24 LINK TO ARTICLE👇👇👇 sciencedirect.com/science/articl… The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant

Dr. J. Kaouk is named as Chair of Cleveland Clinic Dept of Urology Congratulations! Cleveland Clinic Cleveland Clinic Urology

Thank you Raja Khauli MD FACS Khauli. American University of Beirut graduated so many distinguished leaders. I am proud to be an AUB graduate. Alumni Relations Office at AUB Dr. Fadlo Khuri American University of Beirut Medical Center

🧾 New Cheat Sheet on Prostate Cancer Treatment by Stage 🔹 Low-risk: Active surveillance; avoid ADT 🔹 Intermediate-risk: Surgery or RT; ADT case-based 🔹 High-risk: Surgery/RT + long-term ADT #EAUguidelines #ProstateCancer Download Cheat Sheet here: uroweb.org/guidelines/pro…

Overtreatment of #ProstateCancer persists in men with limited life expectancy. Timothy Daskivich Cedars-Sinai and Zach Klaassen Georgia Cancer Center discuss this JAMA Internal Medicine publication and the findings from a study of 243,000 VA patients that reveals increasing rates of definitive

Great Summary for NMIBC management

🚨 Big News from #APCCC26 🚨 APCCC is opening a Call for Abstracts, creating new opportunities for younger investigators & the next generation of leaders in advanced prostate cancer! Full details & submission 👉 apccc.org 📅 Key Dates: 🔹 Submission opens: 1 Sept

BCG-refractory disease presents some of the toughest management challenges in bladder cancer. Dr. Amy Luckenbaugh reviews the evidence and regimens for newly approved Adstiladrin and Anktiva. She also emphasizes that for certain patients, such as those with high tumor burden or